Highlights Nuformix plc

Equities

Market Closed - London S.E. Other stock markets 11:35:11 2024-07-01 EDT			5-day change	1st Jan Change
0.175 ^GBX	+2.94%		-2.78%	-46.15%

06-18	Nuformix shares fall despite interim loss narrowing	AN
06-18	Nuformix plc Reports Earnings Results for the Half Year Ended March 31, 2024	CI

Nuformix shares fall despite interim loss narrowing	06-18	AN
Nuformix plc Reports Earnings Results for the Half Year Ended March 31, 2024	06-18	CI
Nuformix Secures New EU, US Patents for Development Programs	06-17	MT
Nuformix plc Announces Patent Update	06-17	CI
Nuformix announces subscription to raise GBP150,000	03-01	AN
Nuformix plc Reports Earnings Results for the Eighteen Months Ended September 30, 2023	01-15	CI
Nuformix narrows annual loss as develops drug assets	01-03	AN
Earnings Flash (NFX.L) NUFORMIX Reports FY23 Loss GBX-0.12	01-03	MT
Nuformix plc Reports Earnings Results for the Eighteen Months Ended September 30, 2023	01-03	CI
Nuformix plc Announces Notice of Allowance of NXP002 Patent in Japan	23-10-23	CI
Nuformix Updates Oxilio Agreement for NXP001	23-09-18	MT
Nuformix to receive milestone payments from Oxilio pact	23-09-18	AN
Nuformix plc Receives New NXP001 Development Milestone Payments in Updated Oxilio Agreement	23-09-18	CI
Nuformix loss narrows; near-term goal to focus on NXP002 asset	23-05-22	AN
Earnings Flash (NFX.L) NUFORMIX Posts FY23 EPS GBX0.11	23-05-22	MT
Earnings Flash (NFX.L) NUFORMIX Posts Fiscal H1 EPS GBX0.11	23-05-22	MT
Nuformix plc Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-22	CI
Nuformix says NXP002 shows anti-inflammatory effect	23-05-18	AN
Nuformix plc Announces Update Regarding the NXP002 Programme	23-05-18	CI
Sabien works with Empiric; Coro sells in Italy	23-03-27	AN

No results for this search